Diversity of the neurotoxic Conus peptides: A model for concerted pharmacological discovery

Molecular Interventions

Volumn 7, Issue 5, 2007, Pages 251-260

  Olivera, Baldomero M ^a   Teichert, Russell W ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALPHA CONOTOXIN MII; AM 336; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CGX 1051; CGX 1160; CONANTOKIN G; CONOTOXIN; CONTULAKIN G; CYSTEINYLLYSYLSERYLLYSYLGLYCYLALANYLLYSYLCYSTEINYLSERYLLYSYLLEUCYL METHIONYLTYROSYLASPARTYLCYSTEINYLCYSTEINYLSERYLGLYCYLSERYLCYSTEINYLSERYL GLYCYLTHREONYLVALYLGLYCYLARGINYLCYSTEINE; GENE PRODUCT; GLYCYLCYSTEINYLCYSTEINYLSERYLASPARTYLPROLYLARGINYLCYSTEINYL ASPARAGINYLTYROSYLASPARTYLHISTIDYLPROLYLGLUTAMYLISOLEUCYLCYSTEINE; LIGAND; MU CONOTOXIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTENSIN RECEPTOR; NICOTINIC RECEPTOR; NORADRENALIN TRANSPORTER; OMEGA CONOTOXIN; OMEGA CONOTOXIN MVIIA; PEPTIDE; POTASSIUM CHANNEL; SODIUM CHANNEL; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL; XEN 2174; ZICONITIDE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; BIODIVERSITY; CLINICAL TRIAL; COMPETITIVE INHIBITION; CONUS SNAIL; DRUG MECHANISM; DRUG TARGETING; ECOLOGY; GENE MUTATION; HUMAN; MOLECULAR BIOLOGY; MOLECULAR EVOLUTION; MOLECULAR PHYLOGENY; MULTIGENE FAMILY; NEUROPHARMACOLOGY; NEUROTOXICITY; NONHUMAN; PAIN; REVIEW; SPECIES DIFFERENCE; STRUCTURE ACTIVITY RELATION;

ANIMALS; CONUS SNAIL; MOLLUSK VENOMS; NEUROPEPTIDES; PHYLOGENY; RECEPTORS, CHOLINERGIC;

EID: 35349014163     PISSN: 15340384     EISSN: 15432548     Source Type: Journal    
DOI: 10.1124/mi.7.5.7     Document Type: Review

References (58)

1. Newman, D.J., Cragg, G.M., and Snader, K.M. Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod. 66, 1022-1037 (2003).
2. Olivera, B.M. E.E. Just Lecture, 1996. Conus venom peptides, receptor and ion channel targets, and drug design: 50 million years of neuropharmacology. Mol. Bio.l Cell. 8, 2101-2109 (1997). The concept of toxin cabals was first introduced, which provided a partial rationale for the numerous components found in Conus venoms. Combinations of peptide toxins act synergistically to achieve a single physiological endpoint.
3. Olivera, B.M. Conus peptides: Biodiversity-based discovery and exogenomics. J. Biol. Chem. 281, 31173-31177 (2006). The concept of exogenes was advanced as an explanation for the hypermutability of conopeptides. Other exogenously targeted gene products are also expected to be hypermutable.
4. Olivera, B.M., Imperial, J.S., and Bulaj, G. Cone snails and conotoxins: evolving sophisticated neuropharmacology. In Perspectives in Molecular Toxinology (Menez, A., ed) pp. 143-158, John Wiley and Sons Ltd., West Sussex, England (2002).
5. Terlau, H., and Olivera, B.M. Conus venoms: A rich source of ion channel-targeted peptides. Physiol. Rev. 84, 41-68 (2004). Terlau and Olivera provided a comprehensive review of conopeptides and conopeptide gene superfamilies with a discussion of their utility in basic neuroscience research as well as their potential therapeutic applications.
6. Alexander, S.P.H., Mathie, A., and Peters, J.A. Guide to receptors and channels. Br. J. Pharmacol., S1-S180 (2006).
7. Hille, B. Ion channels of excitable membranes, Sinauer Associates(2001).
8. Olivera, B.M. Conus venom peptides: Reflections from the biology of clades and species. Annu. Rev. Ecol. Syst. 33, 25-47 (2002).
9. Olivera, B.M., Walker, C., Cartier, G. E., Hooper, D., Santos, A. D., Schoenfeld, R., Shetty, R., Watkins, M., Bandyopadhyay, P., and Hillyard, D.R. Speciation of cone snails and interspecific hyperdivergence of their venom peptides. Potential evolutionary significance of introns. Ann. N Y Acad. Sci. 870, 223-237 (1999).
10. McIntosh, J.M., Santos, A.D., and Olivera, B.M. Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes. Annu. Rev. Biochem. 68, 59-88 (1999).
11. Sine, S.M., Kreienkamp, H.-J., Bren, N., Maeda, R., and Taylor, P. Molecular dissection of subunit interfaces in the acetylcholine receptor: Identification of determinants of α-conotoxin MI selectivity. Neuron 15, 205-211 (1995).
12. Ellison, M., Haberlandt, C., Gomez-Casati, M.E., Watkins, M., Elgoyhen, A.B., McIntosh, J.M. and Olivera, B.M. α-Rg1A: A novel conotoxin that specifically and potently blocks the α9α10 nAChR. Biochemistry 45, 1511-1517 (2006).
13. Vincler, M., Wittenauer, S., Parker, R., Ellison, M., Olivera, B.M., and McIntosh, J. M. Molecular mechanism for analgesia involving specific antagonism of α9α10 nicotinic acetylcholine receptors. Proc. Natl. Acad. Sci. USA 103, 17880-17884 (2006).
14. Olivera, B.M., Cruz, L.J., de Santos, V. et al. Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using omega-conotoxin from Conus magus venom. Biochemistry 26, 2086-2090 (1987).
15. Changeux, J.P., Galzi, J.L., Devillers-Thiery, A., and Bertrand, D. The functional architecture of the acetylcholine nicotinic receptor explored by affinity labeling and site-directed mutagenesis. Q. Rev. Biophys. 25, 395-432 (1992).
16. Mishina, M., Takai, T., Imoto, K., Noda, M., Takahashi, T., Numa, S., Methfessel, C., and Sakmann, B. Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature 321, 406-411 (1986).
17. Witzemann, V., Barg, B., Criado, M., Stein, E., and Sakmann, B. Developmental regulation of five subunit specific mRNAs encoding acetylcholine receptor subtypes in rat muscle. FEBS Lett. 242, 419-424 (1989).
18. Witzemann, V., Barg, B., Nishikawa, Y., Sakmann, B., and Numa, S. Differential regulation of muscle acetylcholine receptor gamma- and epsilon-subunit mRNAs. FEBS Lett. 223, 104-112 (1987).
19. Jones, A.K., Elgar, G., and Sattelle, D.B. The nicotinic acetylcholine receptor gene family of the pufferfish, Fugu rubripes. Genomics 82, 441-451 (2003).
20. Blount, P. and Merlie, J.P. Molecular basis of the two nonequivalent ligand binding sites of the muscle nicotinic acetylcholine receptor. Neuron 3, 349-357 (1989).
21. Martinez, J.S., Olivera, B.M., Gray, W.R., Craig, A.G., Groebe, D.R., Abramson, S.N., and Mcintosh, J.M. alpha-Conotoxin EI, a new nicotinic acetylcholine receptor antagonist with novel selectivity. Biochemistry 34, 14519-14526 (1995).
22. Jacobsen, R., Yoshikami, D., Ellison, M., Martinez, J., Gray, W.R., Cartier, G.E., Shon, K.J., Groebe, D.R., Abramson, S.N., Olivera, B.M., and McIntosh, J.M. Differential targeting of nicotinic acetylcholine receptors by novel alphaA-conotoxins. J. Biol. Chem. 272, 22531-22537 (1997).
23. Jimenez, E.C., Olivera, B.M., and Teichert, R.W. αC-Conotoxin PrXA: A New Family of Nicotinic Acetylcholine Receptor Antagonists. Biochemistry 46, 8717-8724 (2007).
24. Teichert, R.W., Rivier, J., Torres, J., Dykert, J., Miller, C., and Olivera, B.M. A uniquely selective inhibitor of the mammalian fetal neuromuscular nicotinic acetylcholine receptor. J. Neurosci. 25, 732-736 (2005).
25. Hopkins, C., Grilley, M., Miller, C., Shon, K. J., Cruz, L.J., Gray, W.R., Dykert, J., Rivier, J., Yoshikami, D., and Olivera, B.M. A new family of Conus peptides targeted to the nicotinic acetylcholine receptor. J. Biol. Chem. 270, 22361-22367 (1995).
26. Shon, K.J., Grilley, M., Jacobsen, R., Cartier, G.E., Hopkins, C., Gray, W.R., Watkins, M., Hillyard, D.R., Rivier, J., Torres, J., Yoshikami, D., and Olivera, B.M. A noncompetitive peptide inhibitor of the nicotinic acetylcholine receptor from Conus purpurascens venom. Biochemistry 36, 9581-9587 (1997). References 21-26 collectively demonstrate just one aspect of the amazing diversity of conopeptides: structurally distinct families of conotoxins have evolved to antagonize a single receptor, the neuromuscular nAChR, through several different mechanisms of action.
27. Ellison, M., McIntosh, J.M., and Olivera, B.M. α-conotoxins ImI and ImII. Similar α7 nicotinic receptor antagonists act at different sites. J. Biol. Chem. 278, 757-764 (2003).
28. Olivera, B.M. and Cruz, L. Conotoxins, in retrospect. Toxicon 39, 7-14 (2001).
29. Terlau, H., Shon, K.J., Grilley, M., Stocker, M., Stuhmer, W., and Olivera, B.M. Strategy for rapid immobilization of prey by a fish-hunting marine snail. Nature 381, 148-151 (1996). Components of the lighting-strike cabal were first elucidated. This work helped to explain how the slow-moving cone snails could rapidly immobilize their relatively faster fish prey with venom components.
30. 1-superfamily Conotoxin. Biochemistry, In Press (2007).
31. Buczek, O., Yoshikami, D., Watkins, M., Bulaj, G., Jimenez, E.C., and Olivera, B.M. Characterization of D-amino-acid-containing excitatory conotoxins and redefinition of the I-conotoxin superfamily. FEBS J. 272, 4178-4188 (2005).
32. Gerschenfeld, H.M. Chemical transmission in invertebrate central nervous systems and neuromuscular junctions. Physiol. Rev. 53, 1-119 (1973).
33. Le Novere, N. and Changeux, J.P. Molecular evolution of the nicotinic acetylcholine receptor: An example of multigene family in excitable cells. J. Mol. Evol. 40, 155-172 (1995).
34. Miljanich, G.P. Venom peptides as human pharmaceuticals. Sci. Med. Sept/Oct, 6-15 (1997).
35. Olivera, B.M. ω-Conotoxin MVIIA: From marine snail venom to analgesic drug. In Drugs from the Sea (Fusetani, N., ed) pp. 75-85, Karger, Basel (2000).
36. Miljanich, G. P. Ziconotide: neuronal calcium channel blocker for treating severe chronic pain. Curr. Med. Chem. 11, 3029-3040 (2004). The development of ω-conotoxin MVIIA as an analgesic drug is reviewed, including a discussion of its unique mechanism of action.
37. Bouchet, P., Lozouet, P., Maestrati, P., Heros, V. Assessing the magnitude of species richness in tropical marine environments: Exceptionally high numbers of molluscs at a New Caledonia site. Biol. J. Linn. Soc. Lond. 75, 421-436 (2002).
38. Moreau, S.J. and Guillot, S. Advances and prospects on biosynthesis, structures and functions of venom proteins from parasitic wasps. Insect Biochem. Mol. Biol. 35, 1209-1223 (2005).
39. Sääksjärvi, I.E., Haataja, S., Neuvonen, S., Gauld, I.D., Jussila, R., Salo, J., and Burgos, A.M. High local species richness of parasitic wasps (Hymenoptera: Ichneumonidae; Pimplinae, and Rhyssinae) from the lowland rainforests of Peruvian Amazonia. Ecol. Entomol. 29, 735-743 (2007).
40. Olivera, B.M. and Schmidt, E.W. Exogenes and the origins of biodiversity. (in review).
41. Schmidt, E.W., Nelson, J.T., Rasko, D.A., Sudek, S., Eisen, J.A., Haygood, M.G., Ravel, J. Patellamide A and C biosynthesis by a microcin-like pathway in Prochloron didemni, the cyanobacterial symbiont of Lissoclinum patella. Proc. Natl. Acad. Sci. USA, 102, 7315-7320 (2005).
42. 2+ channels. Neuron 9, 69-77 (1992).
43. Adams, D.J., Smith, A.B., Schroeder, C.I., Yasuda, T., and Lewis, R.J. Omega-conotoxin CVID inhibits a pharmacologically distinct voltage-sensitive calcium channel associated with transmitter release from preganglionic nerve terminals. J. Biol. Chem. 278, 4057-4062 (2003).
44. Scott, D.A., Wright, C.E., and Angus, J. A. Actions of intrathecal omegaconotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat. Eur. J. Pharmacol. 451, 279-286 (2002).
45. Smith, M.T., Cabot, P.J., Ross, F.B., Robertson, A.D., and Lewis, R.J. The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices. Pain 96, 119-127 (2002).
46. Craig, A.G., Norberg, T., Griffin, D.et al. Contulakin-G, an O-glycosylated invertebrate neurotensin. J. Biol. Chem. 274, 13752-13759 (1999).
47. Livett, B.G., Sandall, D.W., Keays, D., Down, J., Gayler, K.R., Satkunanathan, N., and Khalil, Z. Therapeutic applications of conotoxins that target the neuronal nicotinic acetylcholine receptor. Toxicon 48, 810-829 (2006).
48. Satkunanathan, N., Livett, B., Gayler, K., Sandall, D., Down, J., and Khalil, Z. Alpha-conotoxin Vc1.1 alleviates neuropathic pain and accelerates functional recovery of injured neurones. Brain Res. 1059, 149-158 (2005).
49. Nielsen, C.K., Lewis, R.J., Alewood, D., Drinkwater, R., Palant, E., Patterson, M., Yaksh, T.L., McCumber, D., and Smith, M.T. Anti-allodynic efficacy of the chi-conopeptide, Xen2174, in rats with neuropathic pain. Pain 118, 112-124 (2005).
50. Malmberg, A.B., Gilbert, H., McCabe, R.T., and Basbaum, A.I. Powerful antinociceptive effects of the cone snail venom-derived subtype selective NMDA rceptor antagonists conantokins G and T. Pain 101, 101-116 (2003).
51. McIntosh, J.M., Olivera, B.M., Cruz, L.J., and Gray, W.R. γ-carboxyglutamate in a neuroactive toxin. J. Biol. Chem. 259, 14343-14346 (1984).
52. Olivera, B.M., McIntosh, J.M., Clark, C., Middlemas, D., Gray, W.R., and Cruz, L. J. A sleep-inducing peptide from Conus geographus venom. Toxicon 23, 277-282 (1985).
53. Lu, X. C., Williams, A.J., Wagstaff, J.D., Tortella, F.C., and Hartings, J. A. Effects of delayed intrathecal infusion of an NMDA receptor antagonist on ischemic injury and peri-infarct depolarizations. Brain Res. 1056, 200-208 (2005).
54. Barton, M.E. and White, H.S. The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on kindling acquisition and expression. Epilepsy Res. 59, 1-12 (2004).
55. Green, B.R., Catlin, P., Zhang, M.M., Fiedler, B., Bayudan, W., Morrison, A., Norton, R.S., Smith, B.J., Yoshikami, D., Olivera, B.M., and Bulaj, G. Conotoxins containing nonnatural backbone spacers: Cladistic-based design, chemical synthesis, and improved analgesic activity. Chem. Bio. 14, 399-407 (2007).
56. Zhang, M.M., Green, B.R., Catlin, P. et al. Structure/function characterization of μ-conotoxin KIIIA, an analgesic, nearly irreversible blocker of neuronal mammalian sodium channels. J. Biol. Chem. 282, 30699-30706 (2007).
57. Lubbers, N.L., Campbell, T.J., Polakowski, J.S., Bulaj, G., Layer, R.T., Moore, J., Gross, G.J. and Cox, B.F. Postischemic administration of CGX-1051, a peptide from cone snail venom, reduces infarct size in both rat and dog models of myocardial ischemia and reperfusion. J. Cardiovasc. Pharmacol. 46, 141-146 (2005).
58. Zhang, S.J., Yang, X.M., Liu, G.S., Cohen, M.V., Pemberton, K., and Downey, J.M. CGX-1051, a peptide from Conus snail venom, attenuates infarction in rabbit hearts when administered at reperfusion. J. Cardiovasc. Pharmacol. 42, 764-771 (2003).